A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD
Open Access
- 11 May 2022
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 42 (8) , 1823-1835
Abstract
Background: Understanding the genetics of liver disease has the potential to facilitate clinical risk stratification. We recently identified acquired somatic mutations in six genes and one lncRNA in pre‐existing fatty liver disease. We hypothesised that germline variation in these genes might be associated with the risk of developing steatosis and contribute to the prediction of disease severity. Methods: Genome‐wide association study (GWAS) summary statistics were extracted from seven studies (>1.7 million participants) for variants near ACVR2A , ALB , CIDEB , FOXO1 , GPAM , NEAT1 and TNRC6B for: aminotransferases, liver fat, HbA1c, diagnosis of NAFLD, ARLD and cirrhosis. Findings were replicated using GWAS data from multiple independent cohorts. A phenome‐wide association study was performed to examine for related metabolic traits, using both common and rare variants, including gene‐burden testing. Results: There was no evidence of association between rare germline variants or SNPs near five genes ( ACVR2A , ALB , CIDEB , FOXO1 and TNRC6B ) and risk or severity of liver disease. Variants in GPAM (proxies for p.Ile43Val) were associated with liver fat ( p = 3.6 × 10 −13 ), ALT ( p = 2.8 × 10 −39 ) and serum lipid concentrations. Variants in NEAT1 demonstrated borderline significant associations with ALT ( p = 1.9 × 10 −11 ) and HbA1c, but not with liver fat, as well as influencing waist‐to‐hip ratio, adjusted for BMI. Conclusions: Despite the acquisition of somatic mutations at these loci during progressive fatty liver disease, we did not find associations between germline variation and markers of liver disease, except in GPAM. In the future, larger sample sizes may identify associations. Currently, germline polygenic risk scores will not capture data from genes affected by somatic mutations.Keywords
All Related Versions
Funding Information
- Cancer Research UK (C18873/A26813)
- Cancer Research UK (C52489/A19924)
- Cancer Research UK (C52489/A29681)
- Wellcome Trust (216329/Z/19/Z)
This publication has 58 references indexed in Scilit:
- A global reference for human genetic variationNature, 2015
- LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variantsBioinformatics, 2015
- SNiPA: an interactive, genetic variant-centered annotation browserBioinformatics, 2014
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2014
- Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease riskHuman Molecular Genetics, 2009
- Cideb, an ER- and Lipid Droplet-Associated Protein, Mediates VLDL Lipidation and Maturation by Interacting with Apolipoprotein BCell Metabolism, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Regulation of Triglyceride Metabolism II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin actionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- FoxO1 Regulates Multiple Metabolic Pathways in the LiverJournal of Biological Chemistry, 2006
- Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interactionNature, 2003